Liming Lei
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Liming Lei has a total of 71 co-authors. Here are the top co-authors by number of shared publications:
Jiaxin Li
Guangdong Provincial People's Hospital
3 shared publicationsMiaoxian Fang
Guangdong Provincial People's Hospital
3 shared publicationsWeiping Xiong
Guangdong Provincial People's Hospital
3 shared publicationsBowen Gu
Department of Cardiac Surgical Intensive Care Unit, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong Province, China
2 shared publications- Chunbo Chen
Department of Critical Care Medicine, Shenzhen People’s Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), China
2 shared publications Mingyi Zhao
Department of Cardiac Surgery, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China
2 shared publications
Latest Publications
- Open Access
- 21 June 2023
- Published by Springer Nature in Research Square
Risk factors and Diagnostic Indicators for postoperative acute pancreatitis in acute aortic dissection
Objectives: To analyze the incidence, prognosis, risk factors and diagnostic indicatorsof postoperative acute pancreatitis (PAP) in cases of acute type A aortic dissection (ATAAD). Methods: We enrolled 639 patients with ATAAD who underwent thoracic aortic endovascular repair or open surgery at our center from January 2019 to October 2021, and reported the perioperative information. Once patients were diagnosed with PAP, we recorded the diagnostic features, including acute severe epigastric abdominal pain, pancreatic enzyme levels, and abdominal computed tomography or ultrasonography results. Results: PAP in cases of ATAAD was present in 13 patients (13/639, 2.04%), who had a higher proportion of postoperative complications and worse prognosis. The incidences of postoperative hypoxemia [12 (92.31%) vs. 196 (31.31%)], low cardiac output syndrome [2 (15.38%) vs. 13 (2.08%)], need for renal-replacement therapy (RRT) [7 (53.85%) vs. 116 (18.53%)], pneumonia [8 (61.54%) vs. 80 (12.78%)], and bacteremia [5 (38.46%) vs. 27 (4.31%)] were higher in patients with PAP than in the control group. The 90-day mortality of postoperative PAP was 30.77% (4/13). Logistic regression analysis identified coronary and/or atherosclerosis (OR: 7.768, 95%CI [1.463- 41.261], p=0.016), postoperative hypoxemia (OR: 24.429, 95%CI[2.003-298.008, p=0.012), low cardiac output syndrome (OR: 27.382, 95%CI [1.65-454.271, p=0.021), and lactate dehydrogenase level (OR: 1.021, 95%CI [1.005- 1.037], p=0.01) as significant independent risk factors for PAP. Severe epigastric pain is the main manifestation of PAP in ATAAD patients. Conclusions: PAP is a serious complication of ATAAD and is associated with poorer outcomes. Coronary and/or atherosclerosis, postoperative hypoxemia, low cardiac output syndrome, and higher lactate dehydrogenase levels are risk factors for PAP. In cases of progressively elevated pancreatic enzymes or positive abdominal symptoms, a computed tomography scan or magnetic resonance imaging should be performed immediately to rule out PAP.
- 21 June 2023
- Published by Springer Nature in Research Square
Open AccessRisk factors and Diagnostic Indicators for postoperative acute pancreatitis in acute aortic dissection
Objectives: To analyze the incidence, prognosis, risk factors and diagnostic indicatorsof postoperative acute pancreatitis (PAP) in cases of acute type A aortic dissection (ATAAD). Methods: We enrolled 639 patients with ATAAD who underwent thoracic aortic endovascular repair or open surgery at our center from January 2019 to October 2021, and reported the perioperative information. Once patients were diagnosed with PAP, we recorded the diagnostic features, including acute severe epigastric abdominal pain, pancreatic enzyme levels, and abdominal computed tomography or ultrasonography results. Results: PAP in cases of ATAAD was present in 13 patients (13/639, 2.04%), who had a higher proportion of postoperative complications and worse prognosis. The incidences of postoperative hypoxemia [12 (92.31%) vs. 196 (31.31%)], low cardiac output syndrome [2 (15.38%) vs. 13 (2.08%)], need for renal-replacement therapy (RRT) [7 (53.85%) vs. 116 (18.53%)], pneumonia [8 (61.54%) vs. 80 (12.78%)], and bacteremia [5 (38.46%) vs. 27 (4.31%)] were higher in patients with PAP than in the control group. The 90-day mortality of postoperative PAP was 30.77% (4/13). Logistic regression analysis identified coronary and/or atherosclerosis (OR: 7.768, 95%CI [1.463- 41.261], p=0.016), postoperative hypoxemia (OR: 24.429, 95%CI[2.003-298.008, p=0.012), low cardiac output syndrome (OR: 27.382, 95%CI [1.65-454.271, p=0.021), and lactate dehydrogenase level (OR: 1.021, 95%CI [1.005- 1.037], p=0.01) as significant independent risk factors for PAP. Severe epigastric pain is the main manifestation of PAP in ATAAD patients. Conclusions: PAP is a serious complication of ATAAD and is associated with poorer outcomes. Coronary and/or atherosclerosis, postoperative hypoxemia, low cardiac output syndrome, and higher lactate dehydrogenase levels are risk factors for PAP. In cases of progressively elevated pancreatic enzymes or positive abdominal symptoms, a computed tomography scan or magnetic resonance imaging should be performed immediately to rule out PAP.
- Open Access
- 29 April 2023
- Published by Xia & He Publishing in Journal of Translational Critical Care Medicine
- Vol. 5 (2)
Bibliometric Analysis of the Role of Pyroptosis in Sepsis
Background: Emerging evidence has demonstrated that pyroptosis plays a vital role in the development of sepsis. However, few studies have examined this field systemically. We performed the first bibliometric analysis to draw conclusions from and visualize related publications to determine the trends and hotspots in pyroptosis research on sepsis. Methods: A total of 267 publications were retrieved from the Web of Science Core Collection from January 1, 2007 to December 21, 2021. Then, VOSviewer and CiteSpace were used for further analysis. Results: The publications in this field showed an upward trend annually, especially after 2014. Most of the articles were authored by Chinese and American scholars and published in Frontiers in Immunology. Timothy R Billiar published the most related articles, while Shi JJ was cited the most frequently. Co-citation analysis showed that the top 5 co-cited references in this field were in Nature and JAMA's leading co-cited journals. The keywords in this field revolve around the mechanisms of pyroptosis. Guanylate binding protein might be the hotspot, however, based on cluster analysis. Conclusion: The growing interest of researchers in pyroptosis in sepsis reflects the increasing understanding of its underlying mechanisms and the discovery of more clinical effects. These findings suggest that pyroptosis may hold significant potential as a therapeutic target for various diseases.
- 29 April 2023
- Published by Xia & He Publishing in Journal of Translational Critical Care Medicine
- Vol. 5 (2)
Open AccessBibliometric Analysis of the Role of Pyroptosis in Sepsis
Background: Emerging evidence has demonstrated that pyroptosis plays a vital role in the development of sepsis. However, few studies have examined this field systemically. We performed the first bibliometric analysis to draw conclusions from and visualize related publications to determine the trends and hotspots in pyroptosis research on sepsis. Methods: A total of 267 publications were retrieved from the Web of Science Core Collection from January 1, 2007 to December 21, 2021. Then, VOSviewer and CiteSpace were used for further analysis. Results: The publications in this field showed an upward trend annually, especially after 2014. Most of the articles were authored by Chinese and American scholars and published in Frontiers in Immunology. Timothy R Billiar published the most related articles, while Shi JJ was cited the most frequently. Co-citation analysis showed that the top 5 co-cited references in this field were in Nature and JAMA's leading co-cited journals. The keywords in this field revolve around the mechanisms of pyroptosis. Guanylate binding protein might be the hotspot, however, based on cluster analysis. Conclusion: The growing interest of researchers in pyroptosis in sepsis reflects the increasing understanding of its underlying mechanisms and the discovery of more clinical effects. These findings suggest that pyroptosis may hold significant potential as a therapeutic target for various diseases.
- Open Access
- 23 March 2023
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 10
Case report: Acute right ventricular dysfunction after surgery in a pregnant patient with congenital heart disease and aortic dissection
Pregnant women with aortic dissection are hemodynamically outmost complex patients. The two major diagnoses that should be considered in pregnant patients with congenital heart disease (CHD) and acute type A aortic dissection presenting with postoperative right ventricular dysfunction are pulmonary thromboembolism and right ventricular infarction. We present a rare case of postoperative right ventricular dysfunction in pregnant women with CHD and acute aortic dissection, which was diagnosed by pulmonary computed tomography angiography and treated by percutaneous coronary intervention.
- 23 March 2023
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 10
Open AccessCase report: Acute right ventricular dysfunction after surgery in a pregnant patient with congenital heart disease and aortic dissection
Pregnant women with aortic dissection are hemodynamically outmost complex patients. The two major diagnoses that should be considered in pregnant patients with congenital heart disease (CHD) and acute type A aortic dissection presenting with postoperative right ventricular dysfunction are pulmonary thromboembolism and right ventricular infarction. We present a rare case of postoperative right ventricular dysfunction in pregnant women with CHD and acute aortic dissection, which was diagnosed by pulmonary computed tomography angiography and treated by percutaneous coronary intervention.
- Open Access
- 1 March 2023
- Published by Medknow in Journal of Translational Critical Care Medicine
- Vol. 5 (1)
Risk Factors and Prediction of Postoperative Delirium in Aortic Arch Replacement: A Retrospective Cohort Study
Objective: This study aimed to explore the risk factors and prediction of postoperative delirium (POD) in aortic arch replacement. Methods: The preoperative, intraoperative, and postoperative clinical data of patients undergoing aortic arch replacement in our hospital from January 1, 2018, to March 31, 2019, were retrospectively analyzed. According to whether POD occurred, cases were divided into delirium group and control group. The clinical data of the patients were firstly screened by univariate analysis, and then the meaningful variables were analyzed by multivariate logistic regression analysis. The receiver operating characteristic curve was used to analyze the meaningful factors in predicting the occurrence of POD after aortic arch replacement. Results: A total of 162 patients were included in the study. The prevalence of POD was 46.9% (n = 76). The results of univariate and multivariate analyses showed that the intraoperative minimum mean arterial pressure (MAP) (odds ratio [OR] = 0.635, 95% confidence interval [CI] = 0.5510.731, P < 0.001), postoperative C-reactive protein (OR = 1.010, 95% CI = 1.0031.018, P = 0.005), and postoperative infection (OR = 3.148, 95% CI = 1.1188.867, P = 0.030) were the independent risk factors for POD in aortic arch replacement. Among them, the intraoperative minimum MAP has the best prediction effect. When its cutoff value reaches ≤ 49 mmHg, the specificity for predicting POD is 84.88% and the sensitivity is 81.58%. Conclusions: A lower intraoperative minimum MAP is an independent risk factor and has the predictive value for POD in aortic arch replacement.
- 1 March 2023
- Published by Medknow in Journal of Translational Critical Care Medicine
- Vol. 5 (1)
Open AccessRisk Factors and Prediction of Postoperative Delirium in Aortic Arch Replacement: A Retrospective Cohort Study
Objective: This study aimed to explore the risk factors and prediction of postoperative delirium (POD) in aortic arch replacement. Methods: The preoperative, intraoperative, and postoperative clinical data of patients undergoing aortic arch replacement in our hospital from January 1, 2018, to March 31, 2019, were retrospectively analyzed. According to whether POD occurred, cases were divided into delirium group and control group. The clinical data of the patients were firstly screened by univariate analysis, and then the meaningful variables were analyzed by multivariate logistic regression analysis. The receiver operating characteristic curve was used to analyze the meaningful factors in predicting the occurrence of POD after aortic arch replacement. Results: A total of 162 patients were included in the study. The prevalence of POD was 46.9% (n = 76). The results of univariate and multivariate analyses showed that the intraoperative minimum mean arterial pressure (MAP) (odds ratio [OR] = 0.635, 95% confidence interval [CI] = 0.5510.731, P < 0.001), postoperative C-reactive protein (OR = 1.010, 95% CI = 1.0031.018, P = 0.005), and postoperative infection (OR = 3.148, 95% CI = 1.1188.867, P = 0.030) were the independent risk factors for POD in aortic arch replacement. Among them, the intraoperative minimum MAP has the best prediction effect. When its cutoff value reaches ≤ 49 mmHg, the specificity for predicting POD is 84.88% and the sensitivity is 81.58%. Conclusions: A lower intraoperative minimum MAP is an independent risk factor and has the predictive value for POD in aortic arch replacement.
- Open Access
- 14 February 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (4) , 1499
Identification of Distinct Clinical Phenotypes of Heterogeneous Mechanically Ventilated ICU Patients Using Cluster Analysis
This retrospective study aimed to derive the clinical phenotypes of ventilated ICU patients to predict the outcomes on the first day of ventilation. Clinical phenotypes were derived from the eICU Collaborative Research Database (eICU) cohort via cluster analysis and were validated in the Medical Information Mart for Intensive Care (MIMIC-IV) cohort. Four clinical phenotypes were identified and compared in the eICU cohort (n = 15,256). Phenotype A (n = 3112) was associated with respiratory disease, had the lowest 28-day mortality (16%), and had a high extubation success rate (~80%). Phenotype B (n = 3335) was correlated with cardiovascular disease, had the second-highest 28-day mortality (28%), and had the lowest extubation success rate (69%). Phenotype C (n = 3868) was correlated with renal dysfunction, had the highest 28-day mortality (28%), and had the second-lowest extubation success rate (74%). Phenotype D (n = 4941) was associated with neurological and traumatic diseases, had the second-lowest 28-day mortality (22%), and had the highest extubation success rate (>80%). These findings were validated in the validation cohort (n = 10,813). Additionally, these phenotypes responded differently to ventilation strategies in terms of duration of treatment, but had no difference in mortality. The four clinical phenotypes unveiled the heterogeneity of ICU patients and helped to predict the 28-day mortality and the extubation success rate.
- 14 February 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (4) , 1499
Open AccessIdentification of Distinct Clinical Phenotypes of Heterogeneous Mechanically Ventilated ICU Patients Using Cluster Analysis
This retrospective study aimed to derive the clinical phenotypes of ventilated ICU patients to predict the outcomes on the first day of ventilation. Clinical phenotypes were derived from the eICU Collaborative Research Database (eICU) cohort via cluster analysis and were validated in the Medical Information Mart for Intensive Care (MIMIC-IV) cohort. Four clinical phenotypes were identified and compared in the eICU cohort (n = 15,256). Phenotype A (n = 3112) was associated with respiratory disease, had the lowest 28-day mortality (16%), and had a high extubation success rate (~80%). Phenotype B (n = 3335) was correlated with cardiovascular disease, had the second-highest 28-day mortality (28%), and had the lowest extubation success rate (69%). Phenotype C (n = 3868) was correlated with renal dysfunction, had the highest 28-day mortality (28%), and had the second-lowest extubation success rate (74%). Phenotype D (n = 4941) was associated with neurological and traumatic diseases, had the second-lowest 28-day mortality (22%), and had the highest extubation success rate (>80%). These findings were validated in the validation cohort (n = 10,813). Additionally, these phenotypes responded differently to ventilation strategies in terms of duration of treatment, but had no difference in mortality. The four clinical phenotypes unveiled the heterogeneity of ICU patients and helped to predict the 28-day mortality and the extubation success rate.
- Open Access
- 18 August 2022
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 9, 962992
Machine learning approach identified clusters for patients with low cardiac output syndrome and outcomes after cardiac surgery
Background: Low cardiac output syndrome (LCOS) is the most serious physiological abnormality with high mortality for patients after cardiac surgery. This study aimed to explore the multidimensional data of clinical features and outcomes to provide individualized care for patients with LCOS.Methods: The electronic medical information of the intensive care units (ICUs) was extracted from a tertiary hospital in South China. We included patients who were diagnosed with LCOS in the ICU database. We used the consensus clustering approach based on patient characteristics, laboratory data, and vital signs to identify LCOS subgroups. The consensus clustering method involves subsampling from a set of items, such as microarrays, and determines to cluster of specified cluster counts (k). The primary clinical outcome was in-hospital mortality and was compared between the clusters.Results: A total of 1,205 patients were included and divided into three clusters. Cluster 1 (n = 443) was defined as the low-risk group [in-hospital mortality =10.1%, odds ratio (OR) = 1]. Cluster 2 (n = 396) was defined as the medium-risk group [in-hospital mortality =25.0%, OR = 2.96 (95% CI = 1.97–4.46)]. Cluster 3 (n = 366) was defined as the high-risk group [in-hospital mortality =39.2%, OR = 5.75 (95% CI = 3.9–8.5)].Conclusion: Patients with LCOS after cardiac surgery could be divided into three clusters and had different outcomes.
- 18 August 2022
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 9, 962992
Open AccessMachine learning approach identified clusters for patients with low cardiac output syndrome and outcomes after cardiac surgery
Background: Low cardiac output syndrome (LCOS) is the most serious physiological abnormality with high mortality for patients after cardiac surgery. This study aimed to explore the multidimensional data of clinical features and outcomes to provide individualized care for patients with LCOS.Methods: The electronic medical information of the intensive care units (ICUs) was extracted from a tertiary hospital in South China. We included patients who were diagnosed with LCOS in the ICU database. We used the consensus clustering approach based on patient characteristics, laboratory data, and vital signs to identify LCOS subgroups. The consensus clustering method involves subsampling from a set of items, such as microarrays, and determines to cluster of specified cluster counts (k). The primary clinical outcome was in-hospital mortality and was compared between the clusters.Results: A total of 1,205 patients were included and divided into three clusters. Cluster 1 (n = 443) was defined as the low-risk group [in-hospital mortality =10.1%, odds ratio (OR) = 1]. Cluster 2 (n = 396) was defined as the medium-risk group [in-hospital mortality =25.0%, OR = 2.96 (95% CI = 1.97–4.46)]. Cluster 3 (n = 366) was defined as the high-risk group [in-hospital mortality =39.2%, OR = 5.75 (95% CI = 3.9–8.5)].Conclusion: Patients with LCOS after cardiac surgery could be divided into three clusters and had different outcomes.
- Open Access
- 8 June 2022
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 12, 759864
Exosomal miR-4800-3p Aggravates the Progression of Hepatocellular Carcinoma via Regulating the Hippo Signaling Pathway by Targeting STK25
Background: Emerging evidence has shown that exosome microRNAs (miRNAs) regulate the development of hepatocellular carcinoma (HCC). Here, the influences of miR-4800-3p on the progression of HCC were explored.Materials and Methods: The expression of miR-4800-3p in the exosome derived by transforming growth factor beta 1 (TGF-β1)-treated HCC cells and the serum exosome isolated from HCC patients were identified by real-time PCR. The effects of TGF-β1 and the influences of Huh7-secreted exosomes and the effects of miR-4800-3p combined with/without STK25 on cell functions were explored using the EdU assay cloning experiments, wound healing assay, and Transwell assay. The corresponding molecular mechanisms were further detected using Western blot and real-time PCR assays. The combination of miR-4800-3p and STK25 was verified by the dual-luciferase and RNA pulldown assays. The influences of miR-4800-3p on the growth and epithelial–mesenchymal transformation (EMT) of implanted tumors were tested in vivo and further confirmed by Western blot.Results: The miR-4800-3p expression was highly expressed in both exosomes derived by TGF-β1-treated HCC cells and the serum exosomes of HCC patients. In the cases of treatment with both Huh7-derived exosomes, the level of miR-4800-3p expression was highest, and the treatment of TGF-β1 could greatly promote the proliferation, stemness, migration, and invasion of HCC cells via upregulating the markers of stemness and EMT, including CD44, CD133, OCT4, N-cadherin, E-cadherin, and ZO-1. Similar results could be obtained when miR-4800-3p was overexpressed in HCC cells. Furthermore, downregulation of STK25 expression, a direct target gene of miR-4800-3p, could greatly rescue the malignant biological behaviors aggravated by overexpression of miR-4800-3p. This was achieved by suppressing the expression of CD44, CD133, OCT4, N-cadherin, and PCNA and activating the Hippo pathway while increasing E-cadherin and ZO-1. Similar results were also obtained in vivo that knockdown of miR-4800-3p expression suppressed tumor growth induced by Huh7-derived exosomes by mediating the EMT markers and the Hippo signaling pathway.Conclusion: Exosomal miR-4800-3p could accelerate HCC development by regulating the Hippo signal by targeting STK25, which could be used as a new therapeutic target for HCC treatment.
- 8 June 2022
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 12, 759864
Open AccessExosomal miR-4800-3p Aggravates the Progression of Hepatocellular Carcinoma via Regulating the Hippo Signaling Pathway by Targeting STK25
Background: Emerging evidence has shown that exosome microRNAs (miRNAs) regulate the development of hepatocellular carcinoma (HCC). Here, the influences of miR-4800-3p on the progression of HCC were explored.Materials and Methods: The expression of miR-4800-3p in the exosome derived by transforming growth factor beta 1 (TGF-β1)-treated HCC cells and the serum exosome isolated from HCC patients were identified by real-time PCR. The effects of TGF-β1 and the influences of Huh7-secreted exosomes and the effects of miR-4800-3p combined with/without STK25 on cell functions were explored using the EdU assay cloning experiments, wound healing assay, and Transwell assay. The corresponding molecular mechanisms were further detected using Western blot and real-time PCR assays. The combination of miR-4800-3p and STK25 was verified by the dual-luciferase and RNA pulldown assays. The influences of miR-4800-3p on the growth and epithelial–mesenchymal transformation (EMT) of implanted tumors were tested in vivo and further confirmed by Western blot.Results: The miR-4800-3p expression was highly expressed in both exosomes derived by TGF-β1-treated HCC cells and the serum exosomes of HCC patients. In the cases of treatment with both Huh7-derived exosomes, the level of miR-4800-3p expression was highest, and the treatment of TGF-β1 could greatly promote the proliferation, stemness, migration, and invasion of HCC cells via upregulating the markers of stemness and EMT, including CD44, CD133, OCT4, N-cadherin, E-cadherin, and ZO-1. Similar results could be obtained when miR-4800-3p was overexpressed in HCC cells. Furthermore, downregulation of STK25 expression, a direct target gene of miR-4800-3p, could greatly rescue the malignant biological behaviors aggravated by overexpression of miR-4800-3p. This was achieved by suppressing the expression of CD44, CD133, OCT4, N-cadherin, and PCNA and activating the Hippo pathway while increasing E-cadherin and ZO-1. Similar results were also obtained in vivo that knockdown of miR-4800-3p expression suppressed tumor growth induced by Huh7-derived exosomes by mediating the EMT markers and the Hippo signaling pathway.Conclusion: Exosomal miR-4800-3p could accelerate HCC development by regulating the Hippo signal by targeting STK25, which could be used as a new therapeutic target for HCC treatment.
- Open Access
- 1 April 2022
- Published by AME Publishing Company in Annals of Translational Medicine
- Vol. 10 (7) , 417
Downregulated ALKBH5 contributes to myocardial ischemia/reperfusion injury by increasing m6A modification of Trio mRNA
Background: The modification of N6-methyladenosine (m6A) is a dynamic and reversible course that might play a role in cardiovascular disease. However, the mechanisms of m6A modification in myocardial ischemia/reperfusion injury (MIRI) remain unclear. Methods: A mouse model of MIRI and a cell model of oxygen-glucose deprivation/reperfusion (OGD/R) HL-1 cells were employed. In an in vivo study, the total RNA m6A modification levels were determined by dot blot, and the key genes related to m6A modification were screened by real-time quantitative polymerase chain reaction (RT-qPCR) and Western blot. In an in vitro study, the effects of AlkB homolog 5 (ALKBH5), an RNA demethylase, on cell proliferation, cell injury, and apoptosis were detected by the 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay, lactate dehydrogenase (LDH) and cardiac troponin-I (cTnI) levels, and flow cytometry. Besides, the m6A modification-changed and differentially expressed messenger RNA (mRNA) were determined by methylated RNA immunoprecipitation sequencing (MeRIP-seq) and RNA sequencing (RNA-seq) in ALKBH5-overexpressed HL-1 cells. Finally, the mRNA levels of the promising targeted gene were examined by RT-qPCR and its m6A modification levels were examined by MeRIP-qPCR. Results: Our results showed that RNA m6A modification was involved in MIRI, in which ALKBH5 was downregulated. Functionally, by overexpressing or silencing ALKBH5 in experimental cells, we verified its protective properties on cell proliferation, cell injury, and apoptosis in the process of MIRI. Besides, we provided a mass of latent different mRNAs with m6A modification variation in ALKBH5-overexpressed HL-1 cells. Mechanistically, we further screened the most potential targeted mRNAs and suggested that triple functional domain (Trio) mRNA could be upregulated by ALKBH5 by reducing m6A level of Trio. Conclusions: This study demonstrated that the downregulated ALKBH5 might contribute to MIRI process by increasing the m6A modification of Trio mRNA and downregulating Trio.
- 1 April 2022
- Published by AME Publishing Company in Annals of Translational Medicine
- Vol. 10 (7) , 417
Open AccessDownregulated ALKBH5 contributes to myocardial ischemia/reperfusion injury by increasing m6A modification of Trio mRNA
Background: The modification of N6-methyladenosine (m6A) is a dynamic and reversible course that might play a role in cardiovascular disease. However, the mechanisms of m6A modification in myocardial ischemia/reperfusion injury (MIRI) remain unclear. Methods: A mouse model of MIRI and a cell model of oxygen-glucose deprivation/reperfusion (OGD/R) HL-1 cells were employed. In an in vivo study, the total RNA m6A modification levels were determined by dot blot, and the key genes related to m6A modification were screened by real-time quantitative polymerase chain reaction (RT-qPCR) and Western blot. In an in vitro study, the effects of AlkB homolog 5 (ALKBH5), an RNA demethylase, on cell proliferation, cell injury, and apoptosis were detected by the 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay, lactate dehydrogenase (LDH) and cardiac troponin-I (cTnI) levels, and flow cytometry. Besides, the m6A modification-changed and differentially expressed messenger RNA (mRNA) were determined by methylated RNA immunoprecipitation sequencing (MeRIP-seq) and RNA sequencing (RNA-seq) in ALKBH5-overexpressed HL-1 cells. Finally, the mRNA levels of the promising targeted gene were examined by RT-qPCR and its m6A modification levels were examined by MeRIP-qPCR. Results: Our results showed that RNA m6A modification was involved in MIRI, in which ALKBH5 was downregulated. Functionally, by overexpressing or silencing ALKBH5 in experimental cells, we verified its protective properties on cell proliferation, cell injury, and apoptosis in the process of MIRI. Besides, we provided a mass of latent different mRNAs with m6A modification variation in ALKBH5-overexpressed HL-1 cells. Mechanistically, we further screened the most potential targeted mRNAs and suggested that triple functional domain (Trio) mRNA could be upregulated by ALKBH5 by reducing m6A level of Trio. Conclusions: This study demonstrated that the downregulated ALKBH5 might contribute to MIRI process by increasing the m6A modification of Trio mRNA and downregulating Trio.
- Open Access
- 22 July 2020
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2020, 1-10
Dexmedetomidine Attenuates LPS-Induced Monocyte-Endothelial Adherence via Inhibiting Cx43/PKC-α/NOX2/ROS Signaling Pathway in Monocytes
Dexmedetomidine is widely used for sedating patients in operation rooms or intensive care units. Its protective functions against oxidative stress, inflammation reaction, and apoptosis have been widely reported. In present study, we explored the effects of dexmedetomidine on monocyte-endothelial adherence. We built lipopolysaccharide- (LPS-) induced monocyte-endothelial adherence models with U937 monocytes and human umbilical vein endothelial cells (HUVECs) and observed the effects of dexmedetomidine on U937-HUVEC adhesion. Specific siRNA was designed to knock-down Connexin43 (Cx43) expression in U937 monocytes. Gö6976, GSK2795039, and NAC were used to inhibit PKC-α, NOX2, and ROS, respectively. Then, we detected whether dexmedetomidine could downregulate Cx43 expression and its downstream PKC-α/NOX2/ROS signaling pathway activation and ultimately result in the decrease of U937-HUVEC adhesion. The results showed that dexmedetomidine, at its clinically relevant concentrations (0.1 nM and 1 nM), could inhibit adhesion of molecule expression (VLA-4 and LFA-1) and U937-HUVEC adhesion. Simultaneously, it also attenuated Cx43 expression in U937 monocytes. With the downregulation of Cx43 expression, the activity of PKC-α and its related NOX2/ROS signaling pathway were reduced. Inhibiting PKC-α/NOX2/ROS signaling pathway with Gö6976, GSK2795039, and NAC, respectively, VLA-4, LFA-1 expression, and U937-HUVEC adhesion were all decreased. In summary, we concluded that dexmedetomidine, at its clinically relevant concentrations (0.1 nM and 1 nM), decreased Cx43 expression in U937 monocytes and PKC-α associated with carboxyl-terminal domain of Cx43 protein. With the downregulation of PKC-α, the NOX2/ROS signaling pathway was inhibited, resulting in the decrease of VLA-4 and LFA-1 expression. Ultimately, U937-HUVEC adhesion was reduced.
- 22 July 2020
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2020, 1-10
Open AccessDexmedetomidine Attenuates LPS-Induced Monocyte-Endothelial Adherence via Inhibiting Cx43/PKC-α/NOX2/ROS Signaling Pathway in Monocytes
Dexmedetomidine is widely used for sedating patients in operation rooms or intensive care units. Its protective functions against oxidative stress, inflammation reaction, and apoptosis have been widely reported. In present study, we explored the effects of dexmedetomidine on monocyte-endothelial adherence. We built lipopolysaccharide- (LPS-) induced monocyte-endothelial adherence models with U937 monocytes and human umbilical vein endothelial cells (HUVECs) and observed the effects of dexmedetomidine on U937-HUVEC adhesion. Specific siRNA was designed to knock-down Connexin43 (Cx43) expression in U937 monocytes. Gö6976, GSK2795039, and NAC were used to inhibit PKC-α, NOX2, and ROS, respectively. Then, we detected whether dexmedetomidine could downregulate Cx43 expression and its downstream PKC-α/NOX2/ROS signaling pathway activation and ultimately result in the decrease of U937-HUVEC adhesion. The results showed that dexmedetomidine, at its clinically relevant concentrations (0.1 nM and 1 nM), could inhibit adhesion of molecule expression (VLA-4 and LFA-1) and U937-HUVEC adhesion. Simultaneously, it also attenuated Cx43 expression in U937 monocytes. With the downregulation of Cx43 expression, the activity of PKC-α and its related NOX2/ROS signaling pathway were reduced. Inhibiting PKC-α/NOX2/ROS signaling pathway with Gö6976, GSK2795039, and NAC, respectively, VLA-4, LFA-1 expression, and U937-HUVEC adhesion were all decreased. In summary, we concluded that dexmedetomidine, at its clinically relevant concentrations (0.1 nM and 1 nM), decreased Cx43 expression in U937 monocytes and PKC-α associated with carboxyl-terminal domain of Cx43 protein. With the downregulation of PKC-α, the NOX2/ROS signaling pathway was inhibited, resulting in the decrease of VLA-4 and LFA-1 expression. Ultimately, U937-HUVEC adhesion was reduced.
- 1 July 2020
- Published by Elsevier in Cancer Genetics
- Vol. 245, 27-34
Comprehensive network analysis of the molecular mechanisms associated with sorafenib resistance in hepatocellular carcinoma
- 1 July 2020
- Published by Elsevier in Cancer Genetics
- Vol. 245, 27-34
Comprehensive network analysis of the molecular mechanisms associated with sorafenib resistance in hepatocellular carcinoma